mirtazapine has been researched along with Apoplexy in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with ischemic stroke received either 30 mg mirtazapine or no antidepressant medication from day 1 after the stroke in an open, randomized study design." | 9.11 | Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. ( Bohrer, E; Heuser, I; Niedermaier, N; Schlattmann, P; Schulte, K, 2004) |
| "Mirtazapine may be a probably effective treatment in stroke survivors with obstructive sleep apnea who refuse nasal CPAP treatment." | 6.73 | Success and failure of mirtazapine as alternative treatment in elderly stroke patients with sleep apnea-a preliminary open trial. ( Brunner, H, 2008) |
| "Patients with ischemic stroke received either 30 mg mirtazapine or no antidepressant medication from day 1 after the stroke in an open, randomized study design." | 5.11 | Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. ( Bohrer, E; Heuser, I; Niedermaier, N; Schlattmann, P; Schulte, K, 2004) |
| " He had an ischemic stroke and developed a psychotic condition that was successfully treated by lowering the cabergoline and administering quetiapine and mirtazapine together." | 3.91 | Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report. ( Casulari, LA; de Castro, LF; de Fátima Magalhães Gonzaga, M; Kessler, IM; Mendonça, JL, 2019) |
| "Mirtazapine may be a probably effective treatment in stroke survivors with obstructive sleep apnea who refuse nasal CPAP treatment." | 2.73 | Success and failure of mirtazapine as alternative treatment in elderly stroke patients with sleep apnea-a preliminary open trial. ( Brunner, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casulari, LA | 1 |
| de Castro, LF | 1 |
| Kessler, IM | 1 |
| Mendonça, JL | 1 |
| de Fátima Magalhães Gonzaga, M | 1 |
| Niedermaier, N | 1 |
| Bohrer, E | 1 |
| Schulte, K | 1 |
| Schlattmann, P | 1 |
| Heuser, I | 1 |
| Brunner, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Agomelatine in the Prevention of Poststroke Depression[NCT05426304] | Phase 4 | 420 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for mirtazapine and Apoplexy
| Article | Year |
|---|---|
Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Administration Schedule; Female; F | 2004 |
Success and failure of mirtazapine as alternative treatment in elderly stroke patients with sleep apnea-a preliminary open trial.
Topics: Adrenergic alpha-Antagonists; Aged; Body Mass Index; Continuous Positive Airway Pressure; Electromyo | 2008 |
1 other study available for mirtazapine and Apoplexy
| Article | Year |
|---|---|
Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.
Topics: Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; | 2019 |